Lypressin
Generic Name: lypressin
Manufactured by NOVARTIS. Dosage form: SOLUTION. Route: NASAL. Active ingredients: LYPRESSIN (0.185MG/ML). Application: NDA016755.
Overview
Manufactured by NOVARTIS. Dosage form: SOLUTION. Route: NASAL. Active ingredients: LYPRESSIN (0.185MG/ML). Application: NDA016755.
Dosage
Available as solution for nasal use.
Related Medications
Homosalate, Octisalate, Oxybenzone, Avobenzone, Octocrylene
homosalate, octisalate, oxybenzone,avobenzone, octocrylene
Sunscreen
Meningococcal Group B Vaccine
meningococcal group b vaccine
Dosage form: INJECTION, SUSPENSION. Route: INTRAMUSCULAR. Active ingredients: NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN (60 ug/.5mL); NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN (60 ug/.5mL). Category: BLA.
Arsenicum Album, Calcarea Carbonica, Ignatia Amara, Kali Carbonicum, Lachesis Mutus, Natrum Muriaticum, Phosphorus, Pulsatilla (pratensis), Staphysagria
arsenicum album, calcarea carbonica, ignatia amara, kali carbonicum, lachesis mutus, natrum muriaticum, phosphorus, pulsatilla (pratensis), staphysagria
INDICATIONS: May temporarily relieve symptoms of anxiety and nervousness. ** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.